Plus   Neg

Kaman Q4 Net Earnings Rises

Kaman Corp. (KAMN) reported that its fourth-quarter net earnings rose to $39.46 million or $1.41 per share from $23.58 million or $0.84 per share in the prior year.

Net sales for the quarter rose to $237.79 million from $220.86 million in the prior year.

The company expects sales in the range of $860.0 to $880.0 million. It anticipates organic sales growth of 1.0% to 3.0%, despite the headwinds from 737MAX.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Samsung Electronics Co Ltd (SMSN.L, SSNNF.OB, SSNLF.OB) expects that its first-quarter operating profit will increase about 2.73 percent from last year, sales will also increase 4.98 percent. JPMorgan Chase CEO Jamie Dimon said it expects the bank's earnings to be "down meaningfully" in 2020 due to the disruptions created by coronavirus pandemic. He also noted that the U.S. was not adequately prepared for the pandemic. In his annual letter to the company's shareholders, Dimon said that the bank's board may consider suspending the dividend in an extremely adverse scenario. The U.S. Food and Drug Administration launched a national effort to facilitate the development of blood-related therapies to combat the ongoing coronavirus (COVID-19) pandemic. The FDA is focused on two investigational therapies derived from human blood called convalescent plasma and hyperimmune globulin, which are antibody-rich blood products made from blood donated by people who have recovered.
Follow RTT